210 related articles for article (PubMed ID: 27436360)
1. The endothelial adaptor molecule TSAd is required for VEGF-induced angiogenic sprouting through junctional c-Src activation.
Gordon EJ; Fukuhara D; Weström S; Padhan N; Sjöström EO; van Meeteren L; He L; Orsenigo F; Dejana E; Bentley K; Spurkland A; Claesson-Welsh L
Sci Signal; 2016 Jul; 9(437):ra72. PubMed ID: 27436360
[TBL] [Abstract][Full Text] [Related]
2. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd.
Sun Z; Li X; Massena S; Kutschera S; Padhan N; Gualandi L; Sundvold-Gjerstad V; Gustafsson K; Choy WW; Zang G; Quach M; Jansson L; Phillipson M; Abid MR; Spurkland A; Claesson-Welsh L
J Exp Med; 2012 Jul; 209(7):1363-77. PubMed ID: 22689825
[TBL] [Abstract][Full Text] [Related]
3. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
4. VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis.
Matsumoto T; Bohman S; Dixelius J; Berge T; Dimberg A; Magnusson P; Wang L; Wikner C; Qi JH; Wernstedt C; Wu J; Bruheim S; Mugishima H; Mukhopadhyay D; Spurkland A; Claesson-Welsh L
EMBO J; 2005 Jul; 24(13):2342-53. PubMed ID: 15962004
[TBL] [Abstract][Full Text] [Related]
5. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor.
Ha CH; Bennett AM; Jin ZG
J Biol Chem; 2008 Mar; 283(11):7261-70. PubMed ID: 18180305
[TBL] [Abstract][Full Text] [Related]
6. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
9. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival.
Chabot C; Spring K; Gratton JP; Elchebly M; Royal I
Mol Cell Biol; 2009 Jan; 29(1):241-53. PubMed ID: 18936167
[TBL] [Abstract][Full Text] [Related]
10. VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability.
Gorbunova EE; Gavrilovskaya IN; Pepini T; Mackow ER
J Virol; 2011 Mar; 85(5):2296-303. PubMed ID: 21177802
[TBL] [Abstract][Full Text] [Related]
11. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
[TBL] [Abstract][Full Text] [Related]
12. IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis.
Meyer RD; Sacks DB; Rahimi N
PLoS One; 2008; 3(12):e3848. PubMed ID: 19050761
[TBL] [Abstract][Full Text] [Related]
13. Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis.
Hultgren NW; Fang JS; Ziegler ME; Ramirez RN; Phan DTT; Hatch MMS; Welch-Reardon KM; Paniagua AE; Kim LS; Shon NN; Williams DS; Mortazavi A; Hughes CCW
Nat Commun; 2020 Oct; 11(1):5400. PubMed ID: 33106502
[TBL] [Abstract][Full Text] [Related]
14. Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma.
Ye X; Abou-Rayyah Y; Bischoff J; Ritchie A; Sebire NJ; Watts P; Churchill AJ; Bates DO
J Pathol; 2016 Jun; 239(2):139-51. PubMed ID: 26957058
[TBL] [Abstract][Full Text] [Related]
15. Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells.
Kalishwaralal K; Sheikpranbabu S; BarathManiKanth S; Haribalaganesh R; Ramkumarpandian S; Gurunathan S
Angiogenesis; 2011 Mar; 14(1):29-45. PubMed ID: 21061058
[TBL] [Abstract][Full Text] [Related]
16. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.
Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX
Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218
[TBL] [Abstract][Full Text] [Related]
17. Glycation of fibronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-c-Src crosstalk.
Chen T; Dong J; Zhou H; Deng X; Li R; Chen N; Luo M; Li Y; Wu J; Wang L
J Cell Mol Med; 2020 Aug; 24(16):9154-9164. PubMed ID: 32613750
[TBL] [Abstract][Full Text] [Related]
18. YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis.
Wang X; Freire Valls A; Schermann G; Shen Y; Moya IM; Castro L; Urban S; Solecki GM; Winkler F; Riedemann L; Jain RK; Mazzone M; Schmidt T; Fischer T; Halder G; Ruiz de Almodóvar C
Dev Cell; 2017 Sep; 42(5):462-478.e7. PubMed ID: 28867486
[TBL] [Abstract][Full Text] [Related]
19. Annexin A8 promotes VEGF-A driven endothelial cell sprouting.
Heitzig N; Brinkmann BF; Koerdt SN; Rosso G; Shahin V; Rescher U
Cell Adh Migr; 2017 May; 11(3):275-287. PubMed ID: 28060564
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E.
Shibuya M
Endothelium; 2006; 13(2):63-9. PubMed ID: 16728325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
